These Terms and Conditions aim to define the rights, obligations, and responsibilities between the Supplier and Users regarding the use of the voice recording-based medical record creation support service (hereinafter "Service") provided by Huniverse Global Co., Ltd. (hereinafter "Supplier") under the name "MEDIPENCIL" through medipencil.com and medipencil.kr (hereinafter "Service Website"), based on a solution developed by Kailab Co., Ltd. (hereinafter "Developer").

3.1 The contents of these Terms are posted on the Service Website (https://medipencil.com and https://medipencil.kr) operated by the Supplier or on the Service's initial screen, or notified by other means, and become effective to all who agree to these Terms.

3.2 The Supplier may amend these Terms when necessary, within the scope that does not violate relevant laws.

3.3 When these Terms are amended, the Supplier will notify or announce changes by providing reasonable and, where practicable, at least 7 days prior written notice of the update to the Terms, including details of the relevant changes. However, when significant changes to user rights occur, changes will be notified or announced at least 30 days in advance through reasonably possible methods such as email, notification messages, etc.

3.4 If the Supplier notifies or announces according to the previous paragraph and clearly states that failure to express rejection from the notification date until 7 days after the revised Terms take effect will be deemed as approval, but the User does not express their intention, it will be considered that they have approved the amended Terms. If the User does not agree to the revised Terms, they may terminate the usage contract.

3.5 For any increase in Subscription Fees or the conversion the Supplier shall obtain the User’s explicit affirmative consent at least thirty (30) days prior to the change. Failure to obtain explicit consent for fee modifications may result in the continuation of the existing fee structure or termination of the Service.

4.1 Membership registration is made only for those who have completed the registration procedure set by the Supplier through the Service Website (https://medipencil.com and https://medipencil.kr). Users must provide accurate information requested by the Supplier, and service use may be restricted if false information is provided.

4.2 Members must provide additional information requested by the Supplier when necessary for qualification maintenance and management and have an obligation to immediately notify the Supplier if there are changes to registered information.

4.3 A user account is intended for each member's personal use. The user must not give others access to the account. To help maintain control of the account and to prevent unauthorized users from accessing the account, the user should maintain control of the devices used to access the service and not disclose the password or details associated with the account to anyone.

4.4 The Supplier may operate by distinguishing member types according to the nature of the Service and the user's purpose of use and may set different ranges and conditions of available services for each member type.

4.5 If the information provided by a member is inaccurate or does not match the service use purpose, the Supplier may restrict member qualification or suspend service use.

4.6 Users are responsible for checking and complying with relevant laws (Medical Act, Personal Information Protection Act, etc.) of the country or region where they are located when using the Service.

5.1 The Supplier provides the following services through the Service Website (https://medipencil.com and https://medipencil.kr):

1. Medical record creation support function that converts voice recordings to text
2. Application downloads, security updates, and technical support
3. Consultation and grievance handling related to service use

5.2 The Supplier may change all or part of the Service according to technical and operational needs, and changes will be announced in advance through the Service Website.

5.3 The core technology of this Service is developed and maintained by the Developer (Kailab Co., Ltd.), and the Supplier provides the Service to users according to a partnership contract with the Developer. Some functions of the Service may be changed or discontinued depending on the Developer's technical circumstances, and in this case, the Supplier will notify users in advance.

5.4 The Service may be provided to users in South Korea and overseas regions, and the scope, functions, language support, etc. of the Service provided may differ depending on the country or region.

6.1 The Service provided by the Supplier may be offered either free of charge or for a fee on a subscription basis. The fees and payment methods for paid services shall be as stated on the Service Website.

6.2 If User exceeds the limits of the free plan or opt to use any paid features, the User will be charged the applicable subscription or usage fees. These Fees, along with any applicable taxes, duties, or additional charges, will be clearly communicated at the time of sign-up or upgrade and may vary by region, currency, and payment method.

6.3 The Subscription will automatically renew at the end of the applicable Subscription Period, unless User cancels the subscription before the end of the then-current Subscription Period. The cancellation will take effect the day after the last day of the then-current Subscription Period. The Supplier does not provide refunds or credits for any partial Subscription Period, except as expressly stated in these Terms.

6.4 All Fees are non-refundable and non-cancellable except as expressly provided herein or required by law. Users in the EEA have a statutory right to withdraw from this agreement within fourteen (14) days of purchase, while consumers in South Korea have a statutory right to withdraw within seven (7) days of purchase. By initiating use of the Service (pressing "Start Recording" or generating a note), you expressly acknowledge and agree that you are requesting immediate performance and thereby waive your right of withdrawal once service consumption has commenced.

6.5 If the service cannot be used due to reasons attributable to the Supplier, the Supplier shall provide a refund proportionate to the remaining service period or unused portion. However, in cases of mid-term termination due to reasons attributable to the user or a simple change of mind, the refund may be limited or issued after deducting penalties or payment processing fees.

6.6 The Supplier reserves the right to modify the fees, payment terms, pricing structure, subscription plans, usage limits, or any paid or free service offerings at its discretion, including introducing new fees, adjusting existing fees, or changing the scope of services under a specific plan. The Supplier shall make reasonable efforts to provide prior notice of any material changes to the fees or payment terms (via the Service Website, email, etc.). The User’s continued use of the Service following any changed fees shall constitute as acceptance of the revised fees and payment terms.

7.1 All intellectual property rights (copyright, trademark rights, patent rights, technology, and related data, etc.) related to the solution (Dr.Pencil) that forms the basis of this Service (MEDIPENCIL) belong to Kailab Co., Ltd., the Developer.

7.2 "MEDIPENCIL" is a name used by the Supplier for sales purposes based on the Dr.Pencil solution developed by Kailab Co., Ltd., and the intellectual property rights for this name also belong to Kailab Co., Ltd.

7.3 Users shall not copy, modify, distribute, reverse engineer, decompile, disassemble, or otherwise extract source code from software, technology, content, etc. included in the Service.

7.4 In accordance with the license agreement with the developer, the following copyright notice shall be included on the service website, application screens, and outputs. Users shall not arbitrarily delete, modify, or obscure such notice, and any legal liability arising from violation of this provision shall rest with the user. "This product (MediPencil) is copyrighted by KaiLab Co., Ltd. (Powered by Dr.Pencil ⓒ KaiLab Co., Ltd.)"

8.1 The Supplier processes personal information for the following purposes for membership registration and service provision:

1. Confirmation of intention to register and identity verification
2. Prevention of fraudulent use of service and maintenance of member qualification
3. Grievance handling and consultation support related to service use
4. Application updates, security, and problem solving
5. Service improvement and development of new functions
6. Marketing use, event and advertising information delivery (only with explicit consent of the data subject)

9.1 The Supplier and Developer process personal information in compliance with relevant laws such as the Personal Information Protection Act of the Republic of Korea.

9.2 All medical-related data is stored locally on the user's device, and the Supplier and Developer do not collect or separately store patient information and sensitive information.

9.3 Voice data collected during service operation is used only for text conversion (recording) purposes, and the Developer does not store the voice data itself and must delete and dispose of it. This data is not used for storage, analysis, transmission, or other purposes.

9.4 Users must comply with the security guidelines provided by the Supplier to protect their personal information.

9.5 Detailed matters regarding the processing of personal information shall follow the Privacy Policy separately posted on the Service Website (https://medipencil.com and https://medipencil.kr).

10.1 The Supplier respects the personal information protection laws of the country or region where overseas users using the Service are located and provides additional protective measures according to this Article.

10.2 Users in the European Economic Area (EEA) and UK — GDPR Matters

For users subject to the EU General Data Protection Regulation (GDPR) and UK GDPR, the Supplier ensures the following:

The legal basis for the Supplier's processing of user personal information is as follows:

1. Performance of contract for service provision (GDPR Article 6(1)(b))
2. Compliance with legal obligations (GDPR Article 6(1)(c))
3. Explicit consent of the user (GDPR Article 6(1)(a), limited to processing for marketing purposes, etc.)
4. Legitimate interests of the Supplier (GDPR Article 6(1)(f), limited to service improvement and security purposes, etc., within the scope that does not override the fundamental rights and interests of users)

When user personal information is transferred to the Republic of Korea, the Supplier relies on the European Commission’s Adequacy Decision for South Korea (and the mutual adequacy recognition finalized in September 2025), which allows for the free flow of data without additional safeguards. In the event this adequacy status changes, the Supplier will apply Standard Contractual Clauses (SCC) or other appropriate protective measures recognized by GDPR.

Such users may exercise the following rights under GDPR:

Users can exercise these rights through the contact information specified in Article 12, and the Supplier will respond within 30 days from the date of receiving the request. In addition, such users have the right to lodge complaints with the Supervisory Authority in their country of residence.

If the designation of a Data Protection Officer (DPO) is required under GDPR Article 37, the Supplier will designate one and disclose the contact information on the Service Website and Privacy Policy.

10.3 Users in the United States (State Privacy Laws)

For users subject to state privacy laws of the United States, such as the California Consumer Privacy Act (CCPA/CPRA), the Supplier ensures the following:

1. Users have the Right to Know about the categories of personal information the Supplier collects, the purpose of collection, and whether it is shared with third parties
2. Users have the Right to Delete their personal information
3. Users have the Right to Opt-Out of the sale of their personal information
4. The Supplier does not discriminate against users who exercise these rights (Right to Non-Discrimination)
5. As of the announcement date of these Terms, the Supplier does not sell user personal information to third parties

10.4 Users in Other Countries and Regions

For users located in countries or regions other than those mentioned in sections 10.2 and 10.3, the Supplier respects the personal information protection laws of those countries/regions and takes reasonable measures to enable users to exercise their rights guaranteed by relevant laws. Such users may request inquiries and exercise of rights regarding personal information through the contact information specified in Article 14.

10.5 The Supplier may transfer user personal information to regions outside the user's country (including the Republic of Korea), and in this case, applies appropriate protective measures corresponding to the level of protection required by the laws of that country/region. Details regarding the overseas transfer of personal information will be separately provided in the Privacy Policy.

10.6 If voice data processed during service operation may correspond to special categories of personal information under GDPR (health-related data, etc.), the Supplier will obtain Explicit Consent from users for the processing of such data or process it after securing other lawful grounds recognized by GDPR Article 9.

11.1 Members shall not engage in the following acts:

1. Providing false information
2. Fraudulent use of the Service and unauthorized redistribution
3. Infringement of others' rights and violation of laws
4. Acts that infringe intellectual property rights such as copying, reverse engineering, and tampering with software included in the Service
5. Using information obtained through the Service for commercial purposes without the Supplier's prior consent or providing it to third parties

11.2 Members must comply with these Terms, the Supplier's policies, and usage guidelines posted on the Service Website.

11.3 Members must comply with the relevant laws of the country or region where they are located when using the Service, and all responsibility for violations of such laws lies with the member.

12.1 The Supplier may restrict or suspend service provision in the following cases:

1. When a member violates these Terms
2. When technical problems, system inspection, and maintenance are necessary
3. When force majeure events such as natural disasters occur
4. When the Developer's solution supply is discontinued, technical failures occur, or the partnership contract with the Developer is terminated
5. When service provision is restricted by laws, regulations, government measures, etc. of the country or region where the user is located
6. When a User fails to pay Fees when due

12.2 When restricting or suspending the Service, the Supplier will notify in advance through the Service Website, and in urgent cases, may notify afterwards.

12.3 Suspension of Services for reasons (i), or (vi) shall not release the User of its obligation to pay all outstanding Fees. Supplier will not be liable for any damages or losses (including data loss) resulting from a Service Suspension.

12.4 When the Service is discontinued due to reasons in section 12.1 (iv), the Supplier will make reasonable efforts to inform users of the reasons and future action plans.

12.5 In the event that the service is permanently discontinued due to reasons such as the termination of the partnership with the Developer, the Supplier shall provide notice through the service website and official announcements at least thirty (30) days prior to the termination date. Users must save their converted data as separate document files before the service termination date. After the termination of the service, access to and retrieval of data may no longer be possible, including due to the inability to access the application.

13.1 The Service is an administrative support tool only. You agree and acknowledge that the Service:

1. Does not constitute professional medical advice, diagnosis, or treatment recommendations;
2. Is not a substitute for professional clinical judgment and does not establish a doctor-patient relationship between the Supplier and any individual;
3. Is not intended to directly assess, maintain, or improve patient health, nor to directly diagnose or treat any illness or disability.

13.2 The User retains sole and final responsibility for all clinical decisions and the accuracy of all documentation. You acknowledge that AI-generated outputs may contain errors, omissions, or hallucinations. You must exercise independent professional diligence to review, edit, and verify all Service outputs before they are integrated into a medical record or relied upon for any clinical purpose.

14.1 The Supplier is not liable for direct or indirect damages that occur in relation to the use or inability to use the Service unless there is intentional or gross negligence on the Supplier's part.

14.2 The Supplier is not responsible for data loss or loss that occurs during the user's use of the Service.

14.3 This Service is provided based on a solution developed by the Developer (KaiLab Co., Ltd.), and the Supplier's liability may be limited for damages caused by the Developer's fault, such as technical errors in the solution itself or communication failures. In this case, the Supplier will make reasonable efforts to resolve the problem in cooperation with the Developer.

14.4 The voice-to-text conversion results of this Service are of a supplementary reference nature, and the user is responsible for the accuracy and use of the final record. 14.5 If a user violates the laws of the country or region where they are located while using this Service, all legal responsibility arising from this lies with the user, and the Supplier is not responsible for this.

15.1 The operation and customer management of this Service (MEDIPENCIL) is handled by Huniverse Global Co., Ltd.

15.2 Inquiries, consultations, complaints related to service use, and requests to exercise personal information-related rights can be submitted to the following contact information:

15.3 For users subject to GDPR, inquiries regarding personal information can also be submitted to the Data Protection Officer (DPO), and the DPO contact information will be separately provided in the Privacy Policy on the Service Website.

16.1 The governing law for the interpretation and application of these Terms is the law of the Republic of Korea. However, if the application of such law cannot be excluded by the mandatory laws of the country or region where the user is located, such mandatory laws shall apply.

16.2 Any disputes arising in connection with these Terms shall primarily be resolved by mutual agreement of the parties.

16.3 If a lawsuit is filed regarding disputes related to these Terms, the Seoul Central District Court or Daejeon District Court of the Republic of Korea shall be the court of first instance jurisdiction. However, if the user is guaranteed the right to file a lawsuit in the court of their residence under the laws of the country or region where they are located, such provisions shall take precedence.

16.4 Users subject to GDPR have the right to lodge complaints with the supervisory authority of the EU/EEA member state where they reside or to file lawsuits in the courts of that member state.

17.1 Matters not specified in these Terms shall follow the relevant laws and commercial practices of the Republic of Korea.

17.2 If any provision of these Terms is determined to be invalid or unenforceable under the laws of a specific country or region, only that provision shall lose effect within that scope, and the remaining provisions shall continue to be valid.

These Terms shall become effective from March 31, 2026, and Users who have agreed to the existing terms shall be deemed to have agreed to these Terms if they do not express opposition within 7 days from the date of receiving notification according to Article 3.